GB202108828D0 - Novel cancer therapy - Google Patents

Novel cancer therapy

Info

Publication number
GB202108828D0
GB202108828D0 GBGB2108828.1A GB202108828A GB202108828D0 GB 202108828 D0 GB202108828 D0 GB 202108828D0 GB 202108828 A GB202108828 A GB 202108828A GB 202108828 D0 GB202108828 D0 GB 202108828D0
Authority
GB
United Kingdom
Prior art keywords
cancer therapy
novel cancer
novel
therapy
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2108828.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intelligent Omics Ltd
Original Assignee
Intelligent Omics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intelligent Omics Ltd filed Critical Intelligent Omics Ltd
Priority to GBGB2108828.1A priority Critical patent/GB202108828D0/en
Publication of GB202108828D0 publication Critical patent/GB202108828D0/en
Ceased legal-status Critical Current

Links

GBGB2108828.1A 2021-06-18 2021-06-18 Novel cancer therapy Ceased GB202108828D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2108828.1A GB202108828D0 (en) 2021-06-18 2021-06-18 Novel cancer therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2108828.1A GB202108828D0 (en) 2021-06-18 2021-06-18 Novel cancer therapy

Publications (1)

Publication Number Publication Date
GB202108828D0 true GB202108828D0 (en) 2021-08-04

Family

ID=77050550

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2108828.1A Ceased GB202108828D0 (en) 2021-06-18 2021-06-18 Novel cancer therapy

Country Status (1)

Country Link
GB (1) GB202108828D0 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8788444B2 (en) 2008-10-20 2014-07-22 Nottingham Trent University Data analysis method and system

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8788444B2 (en) 2008-10-20 2014-07-22 Nottingham Trent University Data analysis method and system

Non-Patent Citations (14)

* Cited by examiner, † Cited by third party
Title
"Bioreversible Carriers in Drug Design", 1987, AMERICAN PHARMACEUTICAL ASSOCIATION AND PERGAMON PRESS
"Remington's Pharmaceutical Sciences", 1995, MACK PUBLISHING CO., pages: 1447 - 1676
"Synthetic Biology, Part A, Methods in Enzymology", vol. 498, 2011, article "Synthetic Biology, Part B, Computer Aided Design and DNA Assembly", pages: 2 - 500
B. ROEJ. CRABTREEA. KAHN: "DNA Isolation and Sequencing: Essential Techniques", 1996, JOHN WILEY & SONS
D. M. J. LILLEYJ. E. DAHLBERG: "Methods of Enzymology: DNA Structure Part A: Synthesis and Physical Analysis of DNA Methods in Enzymology", 1992, ACADEMIC PRESS
DAVID R. ENGELKEJOHN J. ROSSI: "Methods in Enzymology", vol. 392, 2005, article "RNA Interference", pages: 1 - 454
GAHROUDI ET AL., FEBS LETT., vol. 414, 1997, pages 521 - 526
GONG ET AL., PATHOL ONCOL RES., vol. 18, no. 4, October 2012 (2012-10-01), pages 989 - 96
HAMERS-CASTERMAN ET AL.: "Nature", vol. 363, 1993, pages: 446 - 448
HIGUCHISTELLA: "A.C.S. Symposium Series", vol. 14, 1987, article "Pro-drugs as Novel Delivery Systems"
J. M. POLAKJAMES O'D. MCGEE: "Situ Hybridisation: Principles and Practice", 1984, OXFORD UNIVERSITY PRESS
M.R. GREENJ. SAMBROOK: "Molecular Cloning: A Laboratory Manual", 2012, COLD SPRING HARBOR LABORATORY PRESS
RAMOS-SEVILLANO ET AL., PLOS PATHOG, vol. 12, no. 3, 14 March 2016 (2016-03-14), pages e1005500
RIECHMANN, FEBS LETT, vol. 339, 1994, pages 285 - 290

Similar Documents

Publication Publication Date Title
GB201905780D0 (en) Cancer therapy
GB202301902D0 (en) Combination therapy for cancer
GB202108303D0 (en) Therapy
GB202108828D0 (en) Novel cancer therapy
IL304436A (en) Cancer therapy
GB202001963D0 (en) Cancer therapy
GB202000984D0 (en) Cancer therapy
GB202318158D0 (en) Cancer therapy
GB202302018D0 (en) Cancer therapy
GB202218395D0 (en) Cancer therapy
GB202212918D0 (en) Cancer therapy
IL300171A (en) Combined therapy against cancer
GB202116680D0 (en) Combination therapy for cancer
GB202103673D0 (en) Combination therapy for cancer
GB201901368D0 (en) Cancer therapy
GB202118025D0 (en) Cancer treatment
GB202111930D0 (en) Cancer treatment
GB202113791D0 (en) Novel therapy
GB202107825D0 (en) Novel therapy
GB202010314D0 (en) Cancer treatment
GB202108827D0 (en) Novel antibody cancer therapy
GB202001320D0 (en) Novel Therapy
GB202208893D0 (en) Combination therapy for cancer
GB202117706D0 (en) Therapy
GB202303784D0 (en) Cancer treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)